Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2018.12.004
Abstract: Highlights • First report on PD-L1 therapy and radiotherapy in a HIV positive patient with metastatic Merkel cell carcinoma.• The patient has been tolerated the treatments reasonably well.• The patient has been in complete remission…
read more here.
Keywords:
positive patient;
metastatic merkel;
merkel cell;
patient metastatic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Case Reports in Oncology"
DOI: 10.1159/000502285
Abstract: Merkel cell carcinoma is a rare but aggressive skin cancer. Response to chemotherapy is not durable but avelumab, an anti-PD-L1 inhibitor, showed promising ongoing response in a phase II trial. Checkpoint inhibitors including avelumab are…
read more here.
Keywords:
metastatic merkel;
merkel cell;
cell carcinoma;
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-018-0352-8
Abstract: BackgroundPatients with metastatic Merkel cell carcinoma (mMCC) who experience disease progression on immunotherapy have limited additional standard options. Given evidence of synergism between radiation therapy (RT) and immunotherapy, two patients progressing on PD-1 inhibition were…
read more here.
Keywords:
response;
cell carcinoma;
metastatic merkel;
course ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Indian Journal of Medical and Paediatric Oncology"
DOI: 10.4103/ijmpo.ijmpo_165_18
Abstract: Merkel-cell carcinoma (MCC) is a rare skin malignancy seen in elderly males. It is a highly aggressive tumor with a poor prognosis. Surgery is the mainstay of treatment for localized disease with adjuvant radiation depending…
read more here.
Keywords:
metastatic merkel;
merkel cell;
cell carcinoma;
carcinoma abdominal ... See more keywords